chitosan has been researched along with ursodeoxycholic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cirri, M; Maestrelli, F; Mennini, N; Mura, P; Zerrouk, N | 1 |
| Chung, CW; Jeong, YI; Kang, DH; Kim, CH; Kim, DH; Kwak, TW; Lee, HM | 1 |
| Capuzzo, A; Dalpiaz, A; Ferraro, L; Fogagnolo, M; Gavini, E; Giunchedi, P; Pavan, B; Rassu, G; Salis, A | 1 |
| Beggiato, S; Dalpiaz, A; Ferraro, L; Fogagnolo, M; Hanuskova, M; Leo, E; Maretti, E; Pavan, B; Sacchetti, F | 1 |
| Peng, Y; Qiu, L; Xie, P | 1 |
5 other study(ies) available for chitosan and ursodeoxycholic acid
| Article | Year |
|---|---|
Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components.
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Bile; Caco-2 Cells; Chitosan; Cholagogues and Choleretics; Dehydrocholic Acid; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Synergism; Excipients; Humans; L-Lactate Dehydrogenase; Oxaprozin; Permeability; Propionates; Solubility; Ursodeoxycholic Acid | 2011 |
Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biological Transport; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Chlorophyllides; Cholangiocarcinoma; Drug Carriers; Humans; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Technology, Pharmaceutical; Ursodeoxycholic Acid | 2013 |
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Brain Chemistry; Capsules; Chitosan; Drug Carriers; Male; Prodrugs; Rats, Wistar; Ursodeoxycholic Acid; Zidovudine | 2015 |
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.
Topics: Administration, Intranasal; Animals; Anti-HIV Agents; Bile Acids and Salts; Brain; Cell Line; Chitosan; Drug Carriers; Excipients; Macrophages; Mice; Nanoparticles; Nasal Mucosa; Nose; Particle Size; Prodrugs; Ursodeoxycholic Acid; Zidovudine | 2019 |
Responsive oligochitosan nano-vesicles with ursodeoxycholic acid and exenatide for NAFLD synergistic therapy via SIRT1.
Topics: Animals; Chitosan; Diet, High-Fat; Exenatide; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oligosaccharides; Sirtuin 1; Ursodeoxycholic Acid | 2022 |